Table 2.
Baseline characteristics of the included patients
| Total cohort (n = 114), n (%) | No VTE recurrence (n = 104), n (%) | VTE recurrence (n = 10), n (%) | |
|---|---|---|---|
| Age, mean ± SD (years) | 61.7 ± 13.7 | 61.8 ± 13.7 | 59.9 ± 14.3 |
| Male, n (%) | 58 (51.3) | 51 (50) | 7 (70) |
| Haematological cancer, n (%) | 16 (14.3) | 14 (13.9) | 2 (20) |
| Solid tumour, n (%) | |||
| Breast | 20 (17.9) | 18 (17.8) | 2 (20) |
| Colorectal | 20 (17.9) | 20 (19.8) | 0 (0) |
| Lung | 12 (10.7) | 9 (8.9) | 3 (30) |
| Prostate | 9 (8) | 9 (7.9) | 1 (10) |
| Bladder | 6 (5.4) | 6 (5.9) | 0 (0) |
| Kidney | 3 (2.7) | 2 (2) | 1 (10) |
| Pancreas | 2 (1.8) | 1 (1) | 1 (10) |
| Brain | 2 (1.8) | 2 (2) | 0 (0) |
| Others | 22 (19.6) | 21 | 0 |
| Metastasis | 45 (39.8) | 39 (37.9) | 6 (60) |
| ECOG performance status, n (%) | |||
| 0 | 56 (49.1) | 52 (50.5) | 4 (40) |
| 1 | 51 (44.7) | 46 (44.5) | 5 (50) |
| 2 | 3 (2.6) | 3 (2.9) | 0 (0) |
| 3 | 1 (0.9) | 1 (1) | 0 (0) |
| 4 | 3 (2.6) | 2 (1.9) | 1 (10) |
| VTE presentation, n (%) | |||
| DVT | 61 (53.5) | 55 (53.4) | 6 (60) |
| PE | 33 (28.9) | 33 (32) | 0 (0) |
| DVT+PE | 13 (11.4) | 9 (8.6) | 4 (40) |
| Atypical VTE location | 7 (6.1) | 7 (6.8) | 0 (0) |
| Incidental VTE, n (%) | 33 (29) | 33 (32) | 0 (0) |
| VTE recurrence | 10 (8.8) | — | — |
| Death | 10 (8.8) | 6 (5.9) | 2 (20) |
VTE venous thromboembolism, SD standard deviation, ECOG Eastern Cooperative Oncology Group, DVT deep vein thrombosis, PE pulmonary embolism